Alcon. has been granted a patent for a membrane delamination device designed to separate a membrane from the retina. The device features an elastic component and a blade element with multiple teeth and blades, specifically engineered to cut connective tissues between the membrane and the retina. GlobalData’s report on Alcon gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Alcon, Prosthetic cardiac valves was a key innovation area identified from patents. Alcon's grant share as of July 2024 was 53%. Grant share is based on the ratio of number of grants to total number of patents.
Membrane delamination device for retinal surgery
The patent US12070418B2 describes a specialized membrane delamination device designed for the precise separation of a membrane from the retina of the eye. Central to this device is an elastic component that supports a blade element featuring multiple teeth and blades. The blades are specifically engineered to cut through connective tissues between the membrane and the retina, with each blade strategically positioned within grooves of the elastic component, nestled between adjacent teeth. The device's design includes a pointed distal end that serves as a guide for insertion into the delicate area between the membrane and the retina, enhancing its usability in ophthalmic procedures.
Additionally, the patent outlines the construction of a handle that integrates the membrane delamination device. This handle includes a hand-grip and a base tip, with the elastic component being affixed to the base tip, potentially through injection molding. The elastic component is made of plastic and features a serrated segment with multiple layers, each equipped with teeth that interface with both the membrane and the retina. The design also incorporates cylindrical holes to secure the blade element, ensuring stability during use. Overall, the invention aims to improve the efficiency and safety of retinal surgeries by providing a tool that facilitates the delicate task of membrane delamination.
To know more about GlobalData’s detailed insights on Alcon, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
